
|Articles|October 12, 2012
Trading Away the Medicines of Tomorrow
Author(s)Mike Hennessy
Advertisement
One of the major issues being negotiated right now the amount of protection for the intellectual property of pharmaceutical and biotech companies. And failure to protect the intellectual property rights will actually hurt patients more than the companies.
Click
Newsletter
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Medical Economics
1
Flow Neuroscience wins first FDA approval for at-home brain-stimulation depression treatment
2
ACIP presentation focuses on potential vaccine harm while ignoring benefits, physician expert says
3
What's new in the American Diabetes Association's 2026 diabetes care standards
4
1 in 10 boys meet criteria for gaming addiction; judge approves massive UHG-Amedisys deal; U.S. measles outbreaks – Morning Medical Update
5















